Lisa Escudero
About Lisa Escudero
Lisa A. Escudero is Senior Vice President, Human Resources at Phibro Animal Health Corporation (PAHC), a role she has held since March 2017; she is 63 as of September 15, 2025, with a BA in Psychology and an MS in Human Resources Management from Rutgers University . Company pay-versus-performance disclosures identify Adjusted EBITDA, Free Cash Flow, and Net Sales as the most important performance measures used to link executive compensation to results . Over recent periods, PAHC reported Adjusted EBITDA of $183.7 million and GAAP net income of $48.3 million in FY2025, following FY2024 net sales of $1,017.7 million and Adjusted EBITDA of $111.2 million, with cumulative TSR measured from June 30, 2021 at 111 by FY2025 .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Phibro Animal Health Corporation | Senior Vice President, Human Resources | 2017–present | Leads global HR; supports talent systems and executive ranks broadly referenced in compensation programs . |
| New York Genome Center | Vice President, Human Resources | 2016–2017 | Led HR function for nonprofit biomedical research organization . |
| American Standard Brands | HR Function Lead, member of leadership team | 2008–2016 | Led HR in manufacturing; supported leadership initiatives . |
| Merck & Co. | Director of Human Resources | 1990–2008 | Supported research and manufacturing divisions of a global pharma company . |
| FMC Corporation (Agricultural Chemical Group) | Research Scientist | 1982–1990 | Early-career scientific role prior to HR leadership trajectory . |
External Roles
| Organization | Role | Years |
|---|---|---|
| Not disclosed | — | — |
No external directorships or public-company board roles are disclosed in PAHC’s proxy materials for Lisa Escudero .
Fixed Compensation
Escudero is not listed among PAHC’s Named Executive Officers (NEOs) for FY2023–FY2025; her individual base salary, target bonus, and actual bonus are not itemized in the Summary Compensation Tables and related narratives .
Performance Compensation
| Metric | Weighting | Target | Actual | Payout Outcome | Vesting |
|---|---|---|---|---|---|
| Adjusted EBITDA | Not disclosed (company-level key measure) | Company sets annual targets | Not disclosed (individual) | Not disclosed (individual) | Not disclosed (individual) . |
| Free Cash Flow | Not disclosed (company-level key measure) | Company sets annual targets | Not disclosed (individual) | Not disclosed (individual) | Not disclosed (individual) . |
| Net Sales | Not disclosed (company-level key measure) | Company sets annual targets | Not disclosed (individual) | Not disclosed (individual) | Not disclosed (individual) . |
PAHC states “many of our executive compensation programs apply broadly across our executive ranks,” indicating non-NEO executives typically participate in programs governed by these measures even when individual payouts are not separately disclosed .
Equity Ownership & Alignment
- Individual beneficial ownership for Escudero is not itemized in the security ownership tables; those tables list directors and NEOs individually, plus a combined total for directors and executive officers as a group, but do not break out Escudero specifically .
- Company currently does not grant stock options or option-like instruments; equity awards are seldom awarded to Non-PEO NEOs and have been limited, with a 2025 RSU grant to NEOs (three-year vesting from August 1, 2025) to retain and align interests; no such RSU disclosure is made for Escudero .
- Insider Trading Policy: “Senior Personnel” (including directors) must pre-clear transactions and are prohibited from engaging in derivative securities (options, warrants, SARs, etc.) other than securities received via company compensatory programs .
- Hedging/Pledging: The cited Insider Trading Policy section prohibits derivatives; pledging is not explicitly addressed in the cited text, and no pledging by Escudero is disclosed in the proxy .
Employment Terms
- Start date: March 2017; current role Senior Vice President, Human Resources .
- Non-compete / Non-solicit: PAHC employment agreements for certain NEOs include noncompete and nonsolicitation provisions during employment and for one year thereafter; while this section references NEOs, it indicates customary restrictive covenants at the company level .
- Clawback Policy: Adopted to comply with Exchange Act Section 10D and Nasdaq listing standards; enables recovery of certain incentive compensation from officers and senior executives in the event of a restatement (lookback: three fiscal years) .
- Insider Trading Pre-clearance: Senior Personnel must obtain pre-clearance; prohibited from derivative transactions involving PAHC equity securities .
- Severance / Change-in-Control: Specific severance or CIC terms are disclosed for certain NEOs but not for Escudero; her individual arrangements are not disclosed in proxy materials .
Performance & Track Record
| Period | Company Metric | Value | Notes |
|---|---|---|---|
| FY2025 | Adjusted EBITDA (USD mm) | $183.684 | As reported in pay-versus-performance table . |
| FY2025 | GAAP Net Income (USD mm) | $48.264 | Pay-versus-performance table . |
| FY2024 | Net Sales (USD mm) | $1,017.7 | CD&A business highlights . |
| FY2024 | Adjusted EBITDA (USD mm) | $111.237 | Pay-versus-performance table . |
| FY2021–FY2025 | Cumulative TSR (Index) | 111 (Company), 99 (Peer Group) | PVP table; measurement per Item 201(e) . |
These company outcomes frame the environment during Escudero’s tenure leading HR; PAHC explicitly uses Adjusted EBITDA, Free Cash Flow, and Net Sales to link executive compensation to performance .
Board Governance (for context)
- Compensation Committee: Sam Gejdenson (Chair), Alejandro Bernal, Carol A. Wrenn .
- Audit Committee: E. Thomas Corcoran (Chair), Sam Gejdenson, Carol A. Wrenn .
Compensation Committee Analysis & Policies
- Company does not currently grant option-like instruments and has no timing policy for such awards; if reintroduced, the Board will evaluate appropriate steps .
- Clawback policy and risk assessment processes in place; external consultant FW Cook assisted in risk review of executive compensation practices .
Investment Implications
- Pay-for-performance alignment at PAHC is structurally tied to Adjusted EBITDA, Free Cash Flow, and Net Sales; however, Escudero’s individual compensation components and payouts are not disclosed given she is not an NEO, limiting direct analysis of her incentive alignment versus outcomes .
- Equity-related selling pressure appears limited at the company level due to the absence of option grants and restrictions on derivative transactions; individual RSU holdings for Escudero are not disclosed, reducing visibility into vesting-related supply risk .
- Governance controls (clawback and transaction pre-clearance) reduce misconduct and trading-risk signals; absence of pledging disclosure for Escudero is neutral-to-positive, though pledging policy language was not explicit in cited sections .
- Retention risk cannot be quantified from proxies; company-level restrictive covenants (noncompete/nonsolicit) apply to certain executives for one year post-employment, and HR leadership continuity since 2017 suggests organizational stability, but specific severance/CIC economics for Escudero are not available .